Literature DB >> 22537188

Platelet- and erythrocyte-derived microparticles trigger thrombin generation via factor XIIa.

P E J Van Der Meijden1, M Van Schilfgaarde, R Van Oerle, T Renné, H ten Cate, H M H Spronk.   

Abstract

BACKGROUND: The procoagulant properties of microparticles (MPs) are due to the of the presence of phosphatidylserine (PS) and tissue factor (TF) on their surface. The latter has been demonstrated especially on MPs derived from monocytes.
OBJECTIVES: To investigate the relative contribution of TF and factor (F)XII in initiating coagulation on MPs derived from monocytes, platelets and erythrocytes.
METHODS: Microparticles were isolated from calcium ionophore-stimulated platelets, erythrocytes and monocytic THP-1 cells. MPs were quantified, characterized for cell-specific antigens and analyzed for TF, PS exposure and their thrombin-generating potential.
RESULTS: The MP number was not proportional to PS exposure and the majority of the MPs exposed PS. TF activity was undetectable on platelet- and erythrocyte-derived MPs (< 1 fM nM(-1) PS), whereas monocyte-derived MPs exposed TF (32 fM nM(-1) PS). Platelet-, erythrocyte- and monocyte-derived MPs, but not purified phospholipids, initiated thrombin generation in normal plasma in the absence of an external trigger (lag time < 11 min). Deficiency or inhibition of FVII had no effect on thrombin generation induced by platelet- and erythrocyte-derived MPs, but interfered with monocyte MP-triggered coagulation. Platelet- and erythrocyte-derived MPs completely failed to induce thrombin generation in FXII-deficient plasma. In contrast, monocyte-derived MPs induced similar thrombin generation in normal vs. FXII-deficient plasma.
CONCLUSION: MPs from platelets and erythrocytes not only propagate coagulation by exposing PS but also initiate thrombin generation independently of TF in a FXII-dependent manner. In contrast, monocyte-derived MPs trigger coagulation predominantly via TF.
© 2012 International Society on Thrombosis and Haemostasis.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22537188     DOI: 10.1111/j.1538-7836.2012.04758.x

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN: 1538-7836            Impact factor:   5.824


  86 in total

Review 1.  Thrombosis in Philadelphia negative classical myeloproliferative neoplasms: a narrative review on epidemiology, risk assessment, and pathophysiologic mechanisms.

Authors:  Somedeb Ball; Kyaw Zin Thein; Abhishek Maiti; Kenneth Nugent
Journal:  J Thromb Thrombolysis       Date:  2018-05       Impact factor: 2.300

2.  The polyphosphate-factor XII pathway drives coagulation in prostate cancer-associated thrombosis.

Authors:  Katrin F Nickel; Göran Ronquist; Florian Langer; Linda Labberton; Tobias A Fuchs; Carsten Bokemeyer; Guido Sauter; Markus Graefen; Nigel Mackman; Evi X Stavrou; Gunnar Ronquist; Thomas Renné
Journal:  Blood       Date:  2015-07-07       Impact factor: 22.113

3.  Red blood cells and thrombin generation in sickle cell disease.

Authors:  Matthew F Whelihan; Ming Y Lim; Nigel S Key
Journal:  Thromb Res       Date:  2014-05       Impact factor: 3.944

Review 4.  Extracellular vesicles in renal disease.

Authors:  Diana Karpman; Anne-Lie Ståhl; Ida Arvidsson
Journal:  Nat Rev Nephrol       Date:  2017-07-24       Impact factor: 28.314

5.  The importance of studying red blood cells microparticles.

Authors:  Andrea Piccin; Muriel Van Schilfgaarde; Owen Smith
Journal:  Blood Transfus       Date:  2014-11-18       Impact factor: 3.443

Review 6.  Microparticle analysis in disorders of hemostasis and thrombosis.

Authors:  Micah J Mooberry; Nigel S Key
Journal:  Cytometry A       Date:  2015-02-20       Impact factor: 4.355

Review 7.  Neutrophils: back in the thrombosis spotlight.

Authors:  Denis F Noubouossie; Brandi N Reeves; Brian D Strahl; Nigel S Key
Journal:  Blood       Date:  2019-03-21       Impact factor: 22.113

Review 8.  Influence of red blood cell-derived microparticles upon vasoregulation.

Authors:  Ahmed S Said; Allan Doctor
Journal:  Blood Transfus       Date:  2017-05-15       Impact factor: 3.443

Review 9.  Role of the hemostatic system on sickle cell disease pathophysiology and potential therapeutics.

Authors:  Zahra Pakbaz; Ted Wun
Journal:  Hematol Oncol Clin North Am       Date:  2014-01-18       Impact factor: 3.722

Review 10.  Emerging paradigms in arterial thrombosis.

Authors:  James W Wisler; Richard C Becker
Journal:  J Thromb Thrombolysis       Date:  2014-01       Impact factor: 2.300

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.